Coagulation factor XIII variants with altered thrombin activation rates

被引:11
作者
Andersen, Mette Dahl [1 ]
Kjalke, Marianne [1 ]
Bang, Susanne [1 ]
Lautrup-Larsen, Inger [2 ]
Becker, Peter [1 ]
Andersen, Asser Sloth [2 ]
Olsen, Ole Hvilsted [1 ]
Stennicke, Henning R. [1 ]
机构
[1] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark
[2] Novo Nordisk AS, Diabet Res Unit, DK-2760 Malov, Denmark
关键词
enzyme activation; factor XIII; factor XIII activation peptide; thrombin; PLASMA FACTOR-XIII; ALPHA-THROMBIN; A-SUBUNIT; FIBRIN STRUCTURE; ACTIVE-SITE; PEPTIDE; V34L; POLYMORPHISM; METAANALYSIS; HYDROLYSIS;
D O I
10.1515/BC.2009.142
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Coagulation factor XIII (FXIII) is activated by thrombin and catalyses crosslinking between fibrin monomers thereby providing mechanical strength to the fibrin network. V34L is a common FXIII-A polymorphism found in the activation peptide. FXIII-A V34L is activated faster by thrombin and provides formation of a tighter clot at fibrinogen concentrations in the low end of the physiological range. FXIII-A variants with potentially increased activation rates were generated. Introduction of an optimal thrombin cleavage site, V34L+V35T, increased the activation rate 7.6-fold and facilitated the formation of a fibrin network more resistant to fibrinolysis than obtained with wt FXIII-A. In contrast, introduction of fragments of fibrinopeptide A into the activation peptide resulted in severely impaired activation rates.
引用
收藏
页码:1279 / 1283
页数:5
相关论文
共 31 条
[1]
Characterization of the reciprocal binding sites on human α-thrombin and factor XIII A-chain [J].
Achyuthan, KE .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 178 (1-2) :289-297
[2]
ANDERSEN AS, 2002, Patent No. 200244388
[3]
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure [J].
Ariens, RAS ;
Philippou, H ;
Nagaswami, C ;
Weisel, JW ;
Lane, DA ;
Grant, PJ .
BLOOD, 2000, 96 (03) :988-995
[4]
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms [J].
Ariëns, RAS ;
Lai, TS ;
Weisel, JW ;
Greenberg, CS ;
Grant, PJ .
BLOOD, 2002, 100 (03) :743-754
[5]
Balogh I, 2000, BLOOD, V96, P2479
[6]
BRANSFORD C, 2006, Patent No. 2006056575
[7]
Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus [J].
de lange, Marlies ;
Andrew, Toby ;
Snieder, Harold ;
Ge, Dongliang ;
Futers, T. Simon ;
Standeven, Kristina ;
Spector, Tim D. ;
Grant, Peter J. ;
Ariens, Robert A. S. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) :1914-1919
[8]
Yield improvement of heterologous peptides expressed in yps1-disrupted Saccharomyces cerevisiae strains [J].
Egel-Mitani, M ;
Andersen, AS ;
Diers, I ;
Hach, M ;
Thim, L ;
Hastrup, S ;
Vad, K .
ENZYME AND MICROBIAL TECHNOLOGY, 2000, 26 (9-10) :671-677
[9]
A new global assay of coagulation and fibrinolysis [J].
Goldenberg, NA ;
Hathaway, WE ;
Jacobson, L ;
Manco-Johnson, MJ .
THROMBOSIS RESEARCH, 2005, 116 (04) :345-356
[10]
GREENBERG CS, 1987, BLOOD, V69, P867